A new study done on animals has identified new pathways in which cannabidiol (CBD) affects the brain and nervous system.
Most studies have focused on the endocannabinoid system where the CB1 receptor is located - the receptor THC binds to.
This latest study shows that CBD acts on different receptors to deliver pain and anxiety relief:
Specifically, the findings point to interaction with serotonin (5 HT) receptors that are central to the management of anxiety, and vanilloid (TRPV1) receptors, a target for non-addictive forms of pain relief.
The animal models showed a low dose of CBD administered over 7 days alleviated both pain and anxiety.
If these findings can be replicated in humans we will take another step closer to harnessing CBD's potential to deliver non-addictive pain and anxiety relief.